CRISPR Therapeutics AG·4

Jun 3, 9:45 PM ET

Prasad Raju 4

4 · CRISPR Therapeutics AG · Filed Jun 3, 2025

Insider Transaction Report

Form 4
Period: 2025-05-30
Prasad Raju
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2025-05-30+20,00020,000 total
    Common Shares (20,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
  • [F2]This restricted stock unit award was granted on May 30, 2025 with respect to 20,000 Common Shares, with 100% of the shares vesting on May 30, 2028.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4